Related Experiment Video
Updated: Jul 30, 2026
An “All-laser” Endothelial Transplant
Published on: July 6, 2015
Femtosecond Laser-Assisted Cataract Surgery: A Report by the American Academy of Ophthalmology
Charles C Lin1, Jennifer R Rose-Nussbaumer2, Zaina N Al-Mohtaseb3
1Department of Ophthalmology, Byers Eye Institute, Stanford University, Stanford, California.
Purpose:
To evaluate refractive outcomes, safety, and cost-effectiveness of femtosecond laser-assisted cataract surgery (FLACS) compared with phacoemulsification cataract surgery (PCS).
Methods:
A PubMed search of FLACS was conducted in August 2020. A total of 727 abstracts were reviewed and 33 were selected for full-text review. Twelve articles met inclusion criteria and were included in this assessment. The panel methodologist assigned a level of evidence rating of I to all 12 studies.
Results:
No significant differences were found in mean uncorrected distance visual acuity, best-corrected distance visual acuity, or the percentage of eyes within ± 0.5 and ± 1 diopter of intended refractive target between FLACS and PCS. Intraoperative and postoperative complication rates were similar between the 2 groups, and most studies showed no difference in endothelial cell loss between FLACS and PCS at various time points between 1 and 6 months. In large randomized controlled studies in the United Kingdom and France, FLACS was less cost-effective than PCS.
Conclusions:
Both FLACS and PCS have similar excellent safety and refractive outcomes. At this time, one technique is not superior to the other, but economic analyses performed in some populations have shown that FLACS is less cost-effective.
